Infections of cardiovascular implantable electronic devices and VAD

M. Rizwan Sohail, James M. Steckelberg

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cardiovascular implantable electronic devices (CIED) include permanent pacemakers (PPM), implantable cardioverter-defibrillators (ICD), and cardiac resynchronization therapy (CRT) devices. The reported risk of CIED infection ranges from 1% to 10% and depends on the complexity of the device and host comorbid conditions. Once infected, patients need to undergo complete device removal and systemic antibiotic therapy to achieve cure. Earlier versions of CIEDs required surgical placement of epicardial leads, which was facilitated by sternotomy, and generators were mostly placed in the abdominal area. However, in contemporary practice, most device leads are placed percutaneously via the subclavian vein and the device generator resides in a subcutaneous pocket in the pectoral area. Use of epicardial leads is now reserved for special situations where transvenous lead placement is not possible or deemed high risk due to active or recent bloodstream infection.

Original languageEnglish (US)
Title of host publicationClinical Infectious Disease, Second Edition
PublisherCambridge University Press
Pages280-285
Number of pages6
ISBN (Print)9781139855952, 9781107038912
DOIs
StatePublished - Jan 1 2015

Fingerprint

Cardiovascular Infections
Equipment and Supplies
Cardiac Resynchronization Therapy Devices
Device Removal
Subclavian Vein
Sternotomy
Implantable Defibrillators
Infection
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sohail, M. R., & Steckelberg, J. M. (2015). Infections of cardiovascular implantable electronic devices and VAD. In Clinical Infectious Disease, Second Edition (pp. 280-285). Cambridge University Press. https://doi.org/10.1017/CBO9781139855952.049

Infections of cardiovascular implantable electronic devices and VAD. / Sohail, M. Rizwan; Steckelberg, James M.

Clinical Infectious Disease, Second Edition. Cambridge University Press, 2015. p. 280-285.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sohail, MR & Steckelberg, JM 2015, Infections of cardiovascular implantable electronic devices and VAD. in Clinical Infectious Disease, Second Edition. Cambridge University Press, pp. 280-285. https://doi.org/10.1017/CBO9781139855952.049
Sohail MR, Steckelberg JM. Infections of cardiovascular implantable electronic devices and VAD. In Clinical Infectious Disease, Second Edition. Cambridge University Press. 2015. p. 280-285 https://doi.org/10.1017/CBO9781139855952.049
Sohail, M. Rizwan ; Steckelberg, James M. / Infections of cardiovascular implantable electronic devices and VAD. Clinical Infectious Disease, Second Edition. Cambridge University Press, 2015. pp. 280-285
@inbook{5d507740ec1745769982c4ae4e01c5aa,
title = "Infections of cardiovascular implantable electronic devices and VAD",
abstract = "Cardiovascular implantable electronic devices (CIED) include permanent pacemakers (PPM), implantable cardioverter-defibrillators (ICD), and cardiac resynchronization therapy (CRT) devices. The reported risk of CIED infection ranges from 1{\%} to 10{\%} and depends on the complexity of the device and host comorbid conditions. Once infected, patients need to undergo complete device removal and systemic antibiotic therapy to achieve cure. Earlier versions of CIEDs required surgical placement of epicardial leads, which was facilitated by sternotomy, and generators were mostly placed in the abdominal area. However, in contemporary practice, most device leads are placed percutaneously via the subclavian vein and the device generator resides in a subcutaneous pocket in the pectoral area. Use of epicardial leads is now reserved for special situations where transvenous lead placement is not possible or deemed high risk due to active or recent bloodstream infection.",
author = "Sohail, {M. Rizwan} and Steckelberg, {James M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1017/CBO9781139855952.049",
language = "English (US)",
isbn = "9781139855952",
pages = "280--285",
booktitle = "Clinical Infectious Disease, Second Edition",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Infections of cardiovascular implantable electronic devices and VAD

AU - Sohail, M. Rizwan

AU - Steckelberg, James M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Cardiovascular implantable electronic devices (CIED) include permanent pacemakers (PPM), implantable cardioverter-defibrillators (ICD), and cardiac resynchronization therapy (CRT) devices. The reported risk of CIED infection ranges from 1% to 10% and depends on the complexity of the device and host comorbid conditions. Once infected, patients need to undergo complete device removal and systemic antibiotic therapy to achieve cure. Earlier versions of CIEDs required surgical placement of epicardial leads, which was facilitated by sternotomy, and generators were mostly placed in the abdominal area. However, in contemporary practice, most device leads are placed percutaneously via the subclavian vein and the device generator resides in a subcutaneous pocket in the pectoral area. Use of epicardial leads is now reserved for special situations where transvenous lead placement is not possible or deemed high risk due to active or recent bloodstream infection.

AB - Cardiovascular implantable electronic devices (CIED) include permanent pacemakers (PPM), implantable cardioverter-defibrillators (ICD), and cardiac resynchronization therapy (CRT) devices. The reported risk of CIED infection ranges from 1% to 10% and depends on the complexity of the device and host comorbid conditions. Once infected, patients need to undergo complete device removal and systemic antibiotic therapy to achieve cure. Earlier versions of CIEDs required surgical placement of epicardial leads, which was facilitated by sternotomy, and generators were mostly placed in the abdominal area. However, in contemporary practice, most device leads are placed percutaneously via the subclavian vein and the device generator resides in a subcutaneous pocket in the pectoral area. Use of epicardial leads is now reserved for special situations where transvenous lead placement is not possible or deemed high risk due to active or recent bloodstream infection.

UR - http://www.scopus.com/inward/record.url?scp=84952932010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952932010&partnerID=8YFLogxK

U2 - 10.1017/CBO9781139855952.049

DO - 10.1017/CBO9781139855952.049

M3 - Chapter

AN - SCOPUS:84952932010

SN - 9781139855952

SN - 9781107038912

SP - 280

EP - 285

BT - Clinical Infectious Disease, Second Edition

PB - Cambridge University Press

ER -